Skip to main content

Rubella

  • Chapter
  • First Online:
Vaccines
  • 1216 Accesses

Abstract

For decades, rubella, also known as the “German measles,” was considered a mild viral infection of childhood manifesting with fevers, rash, and lymphadenopathy. In the 1940s, the association between rubella infection during pregnancy and devastating fetal effects, including but not limited to hearing loss, cataracts, and cardiac defects, led to the push for developing a rubella vaccine. During the US rubella epidemic between 1964 and 1965, more than 20,000 infants were born with congenital rubella syndrome, leaving 8000 children deaf and over 3500 children blind. In the United States, the introduction of a live attenuated rubella vaccine subsequently led to a > 99% decline in the incidence of infection. Currently there are fewer than ten cases of rubella infection each year in the United States, most of which are import-related.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gregg NM. Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust. 1941;3:35–46.

    Google Scholar 

  2. World Health Organization. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec. 2011;86:301–16.

    Google Scholar 

  3. Plotkin SA. The history of rubella and rubella vaccination leading to elimination. Clin Infect Dis. 2006;43:S164–8.

    Article  PubMed  Google Scholar 

  4. World Health Organization. Rubella. https://www.who.int/news-room/fact-sheets/detail/rubella. Accessed June 17, 2020.

  5. Grant GB, Desai S, Dumolard L, Kretsinger K, Reef SE. Progress toward rubella and congenital rubella syndrome control and elimination – Worldwide, 2000–2018. MMWR. 2019;68:855–9.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manika Suryadevara .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Suryadevara, M. (2021). Rubella. In: Domachowske, J., Suryadevara, M. (eds) Vaccines. Springer, Cham. https://doi.org/10.1007/978-3-030-58414-6_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-58414-6_27

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-58413-9

  • Online ISBN: 978-3-030-58414-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics